What are the typical symptoms of thrombotic thrombocytopenic purpura (TTP)?

Symptoms of Thrombotic Thrombocytopenic Purpura (TTP)

TTP typically presents with severe thrombocytopenia (usually <30 × 10⁹/L), microangiopathic hemolytic anemia, and various degrees of end-organ ischemic damage—most commonly neurological symptoms, but the classic pentad is rarely seen in full. 1

Core Clinical Manifestations

The presentation of TTP is heterogeneous and often lacks the complete classic pentad (thrombocytopenia, microangiopathic hemolytic anemia, neurological abnormalities, renal dysfunction, and fever), which can lead to dangerous diagnostic delays 2, 3.

Primary Hematologic Features (Nearly Universal)

• Severe thrombocytopenia: Platelet count typically <30 × 10⁹/L 1, 3
• Microangiopathic hemolytic anemia with:
  • Low hemoglobin and hematocrit
  • Elevated lactate dehydrogenase (LDH)
  • Undetectable or very low haptoglobin
  • Schistocytes (fragmented red blood cells) on peripheral smear
  • Indirect hyperbilirubinemia
  • Reticulocytosis
  • Normal coagulation parameters (distinguishes from DIC) 2, 4

Organ Ischemia Manifestations

Neurological symptoms are the most common organ manifestation, occurring in 39%-80% of patients 3:

• Headache
• Confusion or altered mental status
• Speech disturbances
• Seizures
• Focal neurological deficits

In some cases, neurological symptoms may predominate and mask the underlying hematologic emergency, with normal neuroimaging despite severe symptoms 2.

Abdominal pain occurs in 35%-39% of patients 3

Cardiac involvement can manifest as chest pain or myocardial infarction 5

Cutaneous Manifestations

• Petechial rash: While less common as a presenting feature, petechiae can be a pivotal diagnostic clue and may occasionally be the predominant manifestation 6
• Superficial hematomas, particularly on extremities 5

Other Constitutional Symptoms

• Generalized weakness 6
• Fever (part of classic pentad but not always present) 5

Critical Clinical Pitfalls

The absence of the complete pentad should never delay consideration of TTP—most patients do not present with all five classic features 2, 3, 6. The heterogeneous presentation means you must maintain high clinical suspicion with any combination of thrombocytopenia and hemolytic anemia.

Schistocytes may not be present on initial peripheral smear 5, requiring repeat testing if clinical suspicion remains high. In one fatal case, the initial smear was normal, with schistocytes only appearing on day 3 5.

Platelet transfusions should be avoided as they can worsen microvascular thrombosis—lack of response to platelet transfusion should prompt immediate consideration of TTP 2.

Diagnostic Approach When TTP is Suspected

When you encounter thrombocytopenia with microangiopathic hemolytic anemia:

1. Calculate a clinical prediction score immediately (French score or PLASMIC score) to assess likelihood of severe ADAMTS-13 deficiency before laboratory confirmation is available 1, 2

2. Initiate empirical treatment immediately if clinical suspicion is high—do not wait for ADAMTS-13 results, as delays increase morbidity and mortality 2, 3

3. Confirm with ADAMTS-13 activity <10 IU/dL (or <10% of normal) in the proper clinical context 1

The key is recognizing that TTP is a clinical diagnosis requiring immediate action based on the combination of severe thrombocytopenia, microangiopathic hemolytic anemia, and organ ischemia—particularly neurological symptoms—even when the presentation is atypical.